Krka, d.d., Novo mesto Krka-Farma d.o.o. Synthon B.V. Synthon Hispania S.L. Synthon s.r.o.

Poland

All drugs from this manufacturer

  • SUNITINIB KRKA

    The medicine is used in adults for the treatment of gastrointestinal stromal tumors (GIST), metastatic renal cell carcinoma (mRCC), and pancreatic neuroendocrine tumors (pNET).

    Dosage form: capsules, hard

    Active substance Dosage
    sunitinib 12.5 mg

    ATC: L01EX01

  • SUNITINIB KRKA

    The medicinal product is used in adults for the treatment of gastrointestinal stromal tumors (GIST), metastatic renal cell carcinoma (mRCC), and pancreatic neuroendocrine tumors (pNET).

    Dosage form: capsules, hard

    Active substance Dosage
    sunitinib 25 mg

    ATC: L01EX01

  • SUNITINIB KRKA

    The medicinal product is used in adults for the treatment of gastrointestinal stromal tumours (GIST), metastatic renal cell carcinoma, and pancreatic neuroendocrine tumours.

    Dosage form: capsules, hard

    Active substance Dosage
    sunitinib 50 mg

    ATC: L01EX01